/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Siegfried Kasper

University of Iowa(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

2.1K

Papers

54.7K

Citations

114

h-index

784

i10-index

Siegfried Kasper is an academic researcher from University of Iowa. The author has contributed to research in topics: Treatment of Major Depression & Schizophrenia research and treatment & Tryptophan and brain disorders. The author has an h-index of 114, co-authored 1768 publications.

ORCID: 0000-0001-8278-191X

Research Topics

Treatment of Major Depression Schizophrenia research and treatment Tryptophan and brain disorders Bipolar Disorder and Treatment Functional Brain Connectivity Studies

Papers by this author

works

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

2021 · American Journal of Psychiatry · 647 citations

https://doi.org/10.1176/appi.ajp.2020.20081251

Roger S. McIntyre Joshua D. Rosenblat Charles B. Nemeroff Gerard Sanacora

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

2023 · World Psychiatry · 556 citations

https://doi.org/10.1002/wps.21120

Roger S. McIntyre Mohammad Alsuwaidan Bernhard T. Baune Michael Berk

Prognosis and improved outcomes in major depression: a review

2019 · Translational Psychiatry · 470 citations

https://doi.org/10.1038/s41398-019-0460-3

Christoph Kraus Bashkim Kadriu Rupert Lanzenberger Carlos A. Zarate

Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder

2011 · NeuroImage · 398 citations

https://doi.org/10.1016/j.neuroimage.2011.02.064

Andreas Hahn P. Stein Christian Windischberger Andreas Weißenbacher

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

2020 · The International Journal of Neuropsychopharmacology · 396 citations

https://doi.org/10.1093/ijnp/pyaa068

Dawn F. Ionescu Dong‐Jing Fu Xin Qiu Rosanne Lane

Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression

2007 · Annals of Medicine · 262 citations

https://doi.org/10.1080/07853890701278795

Timo Partonen Jens Treutlein Asude Alpman Josef Frank

Research topics

topics

Treatment of Major Depression

Schizophrenia research and treatment

Tryptophan and brain disorders

Bipolar Disorder and Treatment

Functional Brain Connectivity Studies

Chat about Author

Papers

Chat

Click to start Chat